F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, medical record review, and facility P&P review, the facility failed to provide the
necessary care and services to attain or maintain the highest practicable well-being for one of three
sampled residents (Resident 1).
Residents Affected - Few
* The facility failed to follow up with the hospice for the latanoprost eye drop (to treat glaucoma) order for
Resident 1. This failure had the potential to negatively impact the resident's well-being.
Findings:
Review of the facility's P&P titled Hospice Services revised March 2023 showed the nursing home staff may
obtain the orders for care from the designated hospice physicians and communicate the necessary
changes initiated by the hospice provider to the resident's attending physician/practitioner in a timely
manner. The nursing home shall communicate changes in orders provided by the resident's attending
physician/practitioner in the facility if he/she is not the resident's designated physician on the hospice team.
Review of the facility's Hospice and Nursing Facility Services Agreement signed 4/4/24, showed when the
facility personnel are directed by the hospice to administer the prescribed therapies to the residents who
are under hospice's care, including those therapies determined appropriate by the hospice and delineated
in the plan of care, the facility personnel shall administer the therapies in accordance with applicable law
and thefacility policies and procedures.
Review of Resident 1's medical record was initiated on 7/30/24. Resident 1was admitted to the facility on
[DATE].
Review of Resident 1's physician's order for July 2024 showed an order dated 6/3/24, to admit the resident
for hospice care.
Review of Resident 1's MDS Change of Condition assessment dated [DATE], showed Resident 1 was able
to make self-understood and understand others.
Review of Resident 1's plan of care showed a care plan problem for actual impaired vision related to
diabetes mellitus was initiated on 6/22/24, with the interventions to administer the medications as ordered
and monitor for side effects and effectiveness.
Review of Resident 1's hospice physician's order dated 6/29/24, showed an order for latanoprost
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
555733
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555733
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/30/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Pavilion at Sunny Hills
2222 N. Harbor Blvd.
Fullerton, CA 92835
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
solution (used for glaucoma) 0.005 % one drop to both eyes at bedtime.
Level of Harm - Minimal harm
or potential for actual harm
Review of Resident 1's hospice pharmacy delivery receipt showed the eye drop latanoprost solution 0.005
% was received by LVN 2 on 6/30/24.
Residents Affected - Few
Review of Resident 1's SNF physician's orders and MAR from 6/29/24 to 7/8/24, failed to show an order for
latanoprost solution (used for glaucoma) 0.005 % one drop to both eyes at bedtime.
Review of Resident 1's progress notes from 6/29/24 to 7/8/24, failed to show documentation regarding the
new order for the resident's eye drop.
Further review of Resident 1's Order Summary Report for July 2024 showed an order dated 7/9/24, to
administer latanoprost solution 0.005 % one drop in both eyes at bedtime.
On 7/30/24 at 1215 hours, an interview with Resident 1 was conducted. Resident 1 stated he received his
eye drops at night. Resident 1 further stated he had eye discomfort, and it was bothersome for weeks
before he received his eye drops.
On 7/30/24 at 1435 hours, an interview and concurrent medical record review with the MDS nurse was
conducted. The MDS nurse verified the resident had a care plan initiated on 6/22/24, for impaired vision.
The MDS nurse verified the order for latanoprost was received on 7/9/24.
On 7/30/24 at 1523 hours, a telephone interview was conducted with the hospice Case Manager. The
hospice Case Manager verified the order for the latanoprost solution 0.005 % was sent to the facility
through facsimile. The Case Manager stated the eye drop medication latanoprost solution was received by
the facility nurse signed on 6/30/24.
On 7/30/24 at 1633 hours, an interview and concurrent medicalrecord review with the DON was conducted.
The DON stated the hospice agency usually wrote the order or would facsimile the order to the facility and
would call the facility nurse for a new order. The DON stated the nurse who received the medication
delivered by the hospice pharmacy should havefollowed up with the order for the new medication for the
resident. The DON verified the order for latanoprost solution 0.005% was started on 7/9/24, instead of
6/30/24, when the staff received the order from the hospice agency and the eye drop from the pharmacy.
On 7/31/24 at 1329 hours, a telephone interview was conducted with LVN 2. LVN 2 verified she received
the eye drop latanoprost solution for Resident 1 on 6/30/24,and stated it slipped through her mind and was
not able to verify and carry out the order for the latanoprost solution 0.005% eye drop.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555733
If continuation sheet
Page 2 of 2